Anika Therapeutics (ANIK) Tops Q2 EPS by 28c

July 24, 2019 4:09 PM

Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.67, $0.28 better than the analyst estimate of $0.39. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found